公开(公告)号：EP2478358A1

公开(公告)日：2012-07-25

申请号：EP10757143.2

申请日：2010-09-17

申请人： Novartis AG

发明人： FIRESTONE, Brant, Geoffrey ,  LEVINE, Kymberly ,  PORTER, Dale, Alan ,  SULLIVAN, John ,  ZAWEL, Leigh

IPC分类号： G01N33/50

CPC分类号： G01N33/6863 ,  A61K31/427 ,  A61K31/44 ,  A61K31/4439 ,  G01N2333/525 ,  G01N2333/5255 ,  G01N2333/70575

摘要： A method to predict which patients will respond to a IAP inhibiting compound comprising administering an IAP inhibitor compound to a patient, and measuring IL1B, Lymphotoxin alpha (LTa), TWEAK, LIGHT, Fas, TNF alpha or TRAIL levels.